Axitan and QualiTech Team Up for Innovative Animal Health Solutions

Axitan and QualiTech Form Strategic Alliance

Axitan Limited, a prominent biotech enterprise, has announced an exciting strategic partnership with QualiTech. This collaboration is aimed at the development and distribution of innovative endolysin enzyme products specifically designed for the poultry, swine, and ruminant sectors. The focus of Axitan's initiatives is to replace traditional antibiotics in animal feed, positioning them at the forefront of modern animal nutrition.

QualiTech's Role in Distribution

Under the newly forged agreement, QualiTech will serve as the exclusive distributor of Axitan's FORC3® product across the swine, ruminant, and poultry markets in North America, with the exception of broilers. Axitan will maintain exclusive rights for the broiler segment. FORC3® is well-regarded for its effectiveness in targeting Clostridium perfringens, a significant pathogen responsible for necrotic enteritis in poultry. This partnership will enhance the availability of proven solutions in the market.

Novel Products in Development

In addition to distributing FORC3®, Axitan and QualiTech are diligently working together to create new endolysin-based products tailored to address pathogenic challenges within the swine and ruminant markets. QualiTech will hold exclusive distribution rights for these forthcoming products in North America, marking a significant step toward innovation and improvements in animal health.

Vision for Antibiotic-Free Production

Alfred Zimmerman, CEO of Axitan, emphasized the immense potential of endolysins in forging a path toward antibiotic-free production methodologies. He expressed enthusiasm about partnering with QualiTech, highlighting the strategic advantages that come from QualiTech's established presence in the North American animal nutrition market.

Pathogen Mitigation Expertise

Since its inception, Axitan has been a pioneer in integrating endolysins into animal feed, offering targeted solutions for pathogen elimination that were traditionally managed by antibiotics. Their research and development team meticulously formulates endolysins into nutrient-rich feed additives, aiding livestock farmers not only in enhancing productivity but also in bolstering pathogen control. This innovative approach minimizes the risk of antimicrobial resistance, which remains a vital concern in animal husbandry practices.

QualiTech's Commitment

Scott Hine, President of QualiTech’s Animal Nutrition and Agronomy divisions, shared his excitement over the synergy between Axitan’s innovative products and QualiTech’s existing offerings. He noted that this partnership will further qualify their commitment to early-life vitality and performance in animal production, ensuring strong growth trajectories for livestock.

Addressing Industry Challenges

Common pathogens that affect livestock can cost the agricultural sector billions of dollars annually. With consumer preferences shifting toward antibiotic-free and high-protein food options, Axitan and QualiTech are uniquely positioned to lead this essential transition. Their collaboration promises to deliver high-quality ingredients that support animal health and overall well-being.

About QualiTech

Founded in 1967, QualiTech has become a global leader in providing value-added ingredient solutions across various sectors, including food, animal nutrition, and agronomy. Located in Chaska, MN, the company is dedicated to delivering top-notch products that meet the diverse needs of its clientele while promoting health and sustainability.

About Axitan

Axitan specializes in developing, manufacturing, and marketing endolysin products aimed at neutralizing pathogens that threaten food safety and animal production. Committed to facilitating the elimination of antibiotics from animal feed, Axitan is advancing its technology platform to enhance feed additives and ensure the safe production of livestock.

Frequently Asked Questions

What is the purpose of the Axitan and QualiTech partnership?

The partnership aims to develop and distribute innovative endolysin products to replace antibiotics in animal feed, improving animal health and production.

What is FORC3® and how is it used?

FORC3® is an endolysin product specifically targeting Clostridium perfringens, effective in preventing necrotic enteritis in poultry.

How will the new products benefit livestock?

The new endolysin-based products will address pathogenic issues, enhancing livestock health and reducing reliance on antibiotics.

What is the significance of this collaboration for the animal health industry?

This collaboration signifies a shift toward antibiotic-free production methods, responding to consumer demand for healthier animal products.

What does QualiTech offer besides this partnership?

QualiTech provides value-added ingredient solutions and services for food, animal nutrition, and agronomy industries, contributing to overall sustainability and health.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.